Loading organizations...
§ Private Profile · Lagos, Nigeria
MDaaS Global is a technology company.
MDaaS Global operates tech-enabled diagnostic centers, delivering modern healthcare to clinically underserved communities. The company strategically deploys essential diagnostic equipment and integrated technological solutions across Africa, primarily in Nigeria. This enhances access to vital medical imaging and laboratory services, directly improving diagnostic capabilities.
Founded on the insight of profound healthcare access disparities in African communities, MDaaS Global emerged as a health tech enterprise. Its mission was to establish a scalable model, bringing high-quality medical diagnostics to populations lacking such services. This foundational understanding continues to shape the company's strategic expansion and operational framework.
The company serves low-income and clinically underserved populations throughout sub-Saharan Africa. MDaaS Global's vision is to fundamentally transform the region's healthcare landscape, ensuring equitable access to world-class diagnostic services. It commits to building a healthier future, empowering communities with essential tools for effective care.
MDaaS Global has raised $6.6M across 5 funding rounds.
MDaaS Global has raised $6.6M in total across 5 funding rounds.
MDaaS Global has raised $6.6M across 5 funding rounds. Most recently, it raised $3.0M Pre-Series A in March 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 6, 2024 | $3M Seed Plus | Adesuwa Okunbo Rhodes, Llew Claasen | Ventures Platform | Announced |
| Jun 30, 2021 | $2.3M Seed Plus | Llew Claasen | CRI Foundation, Finca Ventures, Future Africa, Techstars | Announced |
| Apr 2, 2019 | $1.1M Venture Round | — | — | Announced |
| Sep 6, 2018 | $100K Venture Round | Kola A. | — | Announced |
| Jun 1, 2018 | $120K Seed | — | Techstars Impact Fund | Announced |
MDaaS Global has raised $6.6M in total across 5 funding rounds.
MDaaS Global's investors include Adesuwa Okunbo Rhodes, Llew Claasen, Ventures Platform, CRI Foundation, FINCA Ventures, Future Africa, Techstars, Kola A., Techstars Impact Fund.
MDaaS Global is a Nigerian health technology company that operates tech-enabled diagnostic centers primarily in clinically underserved communities across Africa. It provides affordable, modern diagnostic services—including radiology, cardiology, laboratory testing, and general health checks—through a network of centers supported by proprietary operating systems that streamline healthcare logistics and sample transportation. Serving over 260,000 patients and partnering with more than 1,300 clinical entities, MDaaS addresses the critical gap in accessible, quality diagnostics outside major urban centers, improving health outcomes for low- to middle-income populations[1][2][4].
The company’s integrated care network and data-driven public health solutions support clinical partners and public health initiatives, enabling efficient patient referrals and collaboration across healthcare providers. MDaaS has demonstrated strong growth momentum, expanding from its first diagnostic center in 2017 to over 16 centers across Nigeria and beginning expansion into Cameroon, with ambitions to operate 100 centers across Africa by 2025[2][5].
Founded in 2016 by a multidisciplinary team in Nigeria, MDaaS Global initially started as an importer of refurbished medical diagnostic equipment. The founders quickly pivoted to operating their own diagnostic centers after recognizing the lack of accessible, affordable diagnostic services in tier 2 and 3 cities. The first center, launched in Ibadan in 2017 under the brand BeaconHealth Diagnostics, became profitable within five months. This early success validated their model of centralized, tech-enabled diagnostic centers serving surrounding clinics and hospitals, which led to rapid expansion across Nigerian states such as Lagos, Ogun, and Oyo[2][5].
The company’s evolution reflects a strategic shift from equipment sales to a service-oriented model that integrates technology, logistics, and clinical partnerships to deliver high-quality diagnostics at scale. Key investors include Techstars, Future Africa, Google for Startups, Consonance Investment Managers, and HealthCap, supporting MDaaS’s growth and innovation[1][4].
MDaaS Global rides the trend of digital health transformation and decentralization of healthcare services in Africa, addressing the continent’s diagnostic service deficit. The timing is critical as Africa faces a growing burden of noncommunicable diseases and a lack of accessible preventive care. Market forces such as increasing mobile connectivity, rising health awareness, and demand for affordable healthcare create favorable conditions for MDaaS’s model.
By integrating technology with healthcare delivery, MDaaS not only improves access but also enhances data flow and coordination among healthcare providers, influencing the broader ecosystem toward more efficient, scalable healthcare solutions. Its model exemplifies how tech-enabled service delivery can overcome infrastructure and resource limitations in emerging markets[1][7].
MDaaS Global is poised for significant expansion, aiming to operate 100 diagnostic centers across Africa by 2025 and serve over a million patients annually. Future growth will likely be shaped by continued technological innovation, deeper integration with health insurance and public health systems, and geographic expansion into other African countries with similar healthcare challenges.
As healthcare digitization accelerates, MDaaS’s influence may evolve from a diagnostic service provider to a key player in Africa’s health data ecosystem, enabling predictive analytics and population health management. Their success could serve as a blueprint for sustainable, tech-driven healthcare delivery in emerging markets, addressing critical gaps in access and quality.
In summary, MDaaS Global is transforming healthcare diagnostics in Africa by combining technology, affordability, and strategic partnerships to serve underserved communities, positioning itself as a vital contributor to the continent’s health innovation landscape[1][2][5].